| Detected | Trial | Change |
|---|---|---|
| 2026-06-06 | NCT05723055 Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory… |
date change Primary completion pushed: 2026-05 -> 2026-12 |
| 2026-06-06 | NCT05723055 Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory… |
date change Completion pushed: 2028-04 -> 2028-11 |
| 2026-05-27 | NCT06585774 A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic… |
Trial sites expanded: 119 -> 122 locations |
| 2026-05-23 | NCT06388564 A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib… |
overall status: "Recruiting" → "Active Not Recruiting" |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-10 | NCT07638982 Axatilimab + CAR-T for High-Risk Lymphoma | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06585774 | A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic… | Chronic Graft-versus-host-disease | Recruiting |
| NCT06263478 | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Axatilimab Monotherapy… | Chronic Graft-versus-host-disease | Active, Not Recruiting |
| NCT06821542 | A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic… | Chronic Graft-versus-host-disease | Active, Not Recruiting |
| Phase 2 | |||
| NCT07011810 | Axatilimab for Sclerotic Chronic Graft-versus-Host Disease | Chronic Graft Versus Host Disease | Recruiting |
| NCT05491226 | Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and… | TNBC - Triple-Negative Breast Cancer | Recruiting |
| NCT06663722 | Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic… | Chronic Graft Versus Host Disease | Recruiting |
| NCT07124078 | A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants… | Chronic Graft-versus-host-disease | Recruiting |
| NCT04710576 | A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host… | Chronic Graft-versus-host-disease | Active, Not Recruiting |
| NCT06132256 | MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis… | Idiopathic Pulmonary Fibrosis | Active, Not Recruiting |
| NCT07349771 | Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease… | Hematopoietic and Lymphatic System Neoplasm | Not Yet Recruiting |
| NCT07015853 | ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination… | TNBC - Triple-Negative Breast Cancer | Not Yet Recruiting |
| NCT06388564 | A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib… | Chronic Graft-versus-host-disease | Active, Not Recruiting |
| NCT05723055 | Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory… | Hodgkin Lymphoma | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT06320405 | Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients… | Advanced Malignant Solid Neoplasm | Recruiting |
| NCT07128381 | Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With… | Myelofibrosis (MF) | Recruiting |
| NCT06843408 | A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent or… | Chronic Graft-versus-host-disease | Recruiting |
| NCT06523556 | Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase… | Atypical Chronic Myeloid Leukemia | Recruiting |
| Phase 1 | |||
| NCT06959537 | A Phase Ib Study of Novel Combination (New) of Low Dose Oral CyclophoSphamide (s) to… | Breast Cancer | Recruiting |
| NCT07511062 | Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML | Acute Myeloid Leukemia | Not Yet Recruiting |
| NCT07638982 | Axatilimab + CAR-T for High-Risk Lymphoma | Diffuse Large B Cell Lymphoma (DLBCL) | Not Yet Recruiting |